1. Home
  2. AKTX vs PMAX Comparison

AKTX vs PMAX Comparison

Compare AKTX & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • PMAX
  • Stock Information
  • Founded
  • AKTX N/A
  • PMAX 2019
  • Country
  • AKTX United States
  • PMAX Hong Kong
  • Employees
  • AKTX N/A
  • PMAX N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • PMAX
  • Sector
  • AKTX Health Care
  • PMAX
  • Exchange
  • AKTX Nasdaq
  • PMAX Nasdaq
  • Market Cap
  • AKTX 32.8M
  • PMAX 32.0M
  • IPO Year
  • AKTX N/A
  • PMAX 2024
  • Fundamental
  • Price
  • AKTX $1.24
  • PMAX $0.44
  • Analyst Decision
  • AKTX
  • PMAX
  • Analyst Count
  • AKTX 0
  • PMAX 0
  • Target Price
  • AKTX N/A
  • PMAX N/A
  • AVG Volume (30 Days)
  • AKTX 25.4K
  • PMAX 4.2M
  • Earning Date
  • AKTX 02-15-2025
  • PMAX 02-14-2025
  • Dividend Yield
  • AKTX N/A
  • PMAX N/A
  • EPS Growth
  • AKTX N/A
  • PMAX N/A
  • EPS
  • AKTX N/A
  • PMAX 0.04
  • Revenue
  • AKTX N/A
  • PMAX $5,970,263.00
  • Revenue This Year
  • AKTX N/A
  • PMAX N/A
  • Revenue Next Year
  • AKTX N/A
  • PMAX N/A
  • P/E Ratio
  • AKTX N/A
  • PMAX $10.26
  • Revenue Growth
  • AKTX N/A
  • PMAX 30.05
  • 52 Week Low
  • AKTX $0.90
  • PMAX $0.34
  • 52 Week High
  • AKTX $4.40
  • PMAX $4.70
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 51.97
  • PMAX N/A
  • Support Level
  • AKTX $1.10
  • PMAX N/A
  • Resistance Level
  • AKTX $1.39
  • PMAX N/A
  • Average True Range (ATR)
  • AKTX 0.13
  • PMAX 0.00
  • MACD
  • AKTX -0.00
  • PMAX 0.00
  • Stochastic Oscillator
  • AKTX 61.54
  • PMAX 0.00

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

Share on Social Networks: